Age-related macular degeneration (AMD) is the most common cause of severe visual loss in people over the age of 50 in Australia. Approximately 200 million people worldwide are living with AMD, with concern that cases will continue to rise.
If you have AMD, being aware of signs and symptoms, early detection and treatment, and knowing how to monitor your symptoms is the key to managing this condition.
Macular Degeneration occurs at the part of the retina that provides central, detailed, and colour vision. A person who is typically affected by AMD may have difficulty performing everyday tasks requiring good, precise central vision, such as reading, watching TV, undertaking daily activities, and driving, however, less precise peripheral vision remains unaffected.
The location of the macula is at the very back of the eye, in line with your visual axis. The eye functions similarly to a camera; light pass through the cornea and lens onto the retina, then the retina absorbs this light and converts this light into an image.
The retina is lined with photoreceptor cells, which allow us to see fine detail and colours. Underneath this layer is the Retinal-Pigment-Epithelial Layer (RPE). The proper functioning of the RPE layer is essential for photoreceptor health. Broadly there are two types of AMD, dry and wet. All patients with this condition will have dry AMD where there is a build-up of waste material underneath the RPE layer known as Drusen, an early sign of AMD. Later, the photoreceptors may be damaged causing retinal thinning. In approximately 25% of patients AMD may progress to the wet stage where, small blood vessels may grow under the retina and bleed, causing further damage to the eye and the patient’s vision.
There are several factors known to be associated with an increased risk of developing macular degeneration.
Treatment dry macular degeneration is difficult. Wet AMD is now treated with injections of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) into the eye. There are several types available (subsidised through the PBS).The drugs block VEGF receptors, thereby reducing abnormal blood vessel growth, eliminating accumulated fluid and retaining the health of the photoreceptors. Early intervention is essential in reducing the risk of further vision loss in patients with Wet AMD.
A modified Amsler Grid Chart is a very useful modality to monitor for early disease progression. An Amsler Grid and more information can be found on the Macular Disease Foundation of Australia website by clicking here:
To check for macular changes using an Amsler grid at home:
If an Amsler grid is not available, look at objects that are straight such as tiles on the floor or door frames. Watch out for any parts of the object that are missing or waviness or distortion in the object.
In the early stages of Wet AMD these symptoms develop more rapidly. Prompt intervention and treatment is required in order to preserve your vision, please call your eye specialist to make an appointment as soon as possible if you develop rapid onset of these symptoms.
A dilated slit lamp examination (using dilating eye drops) and an Optical Coherence Tomography (OCT) scan are very effective tools for diagnosing AMD. OCT imaging allows acquisition of cross-sectional images of the macula which pinpoints the exact location of pathology in the retina and provides the ophthalmologist with detailed information about the macular and surrounding areas. In particular, the ophthalmologist will look for drusen, fluid accumulation, photoreceptor damage/loss and new vessel growth (neovascularisation) in the macula.
Intra-vitreal injections are undertaken under topical and local anaesthesia using a sterile technique in clinic. The technique involves:
Intravitreal Anti-VEGF injections are a safe and low risk procedure, undertaken using a sterile technique in procedure room.
Adverse reactions post injection may include: mild discomfort or subconjunctival haemorrhage at the site of injection. These symptoms usually dissipate within 1-3 days post injection.
Sight threatening risks are very rare. Your ophthalmologist will discuss all risk factors with you prior to your initial injection.
If you have severe pain, severe redness and/or concerning blurred vision following intravitreal injection, please contact your eye specialist urgently using the number provided on your injection information sheet or visit the Royal Victorian Eye & Ear Hospital (Open 24 hours Ph. 9929 8666).